| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 677.10M | 1.02B | 997.03M | 663.96M | 580.55M |
| Gross Profit | 60.61M | 87.70M | 95.38M | 60.61M | 71.66M |
| EBITDA | 18.80M | 35.64M | 54.29M | 20.89M | 43.63M |
| Net Income | -7.23M | 16.10M | 28.26M | 2.25M | 28.61M |
Balance Sheet | |||||
| Total Assets | 213.56M | 345.51M | 330.05M | 298.47M | 198.44M |
| Cash, Cash Equivalents and Short-Term Investments | 75.94M | 73.19M | 70.98M | 73.58M | 70.55M |
| Total Debt | 13.91M | 38.38M | 68.16M | 116.16M | 37.46M |
| Total Liabilities | 81.56M | 206.37M | 83.98M | 203.71M | 96.94M |
| Stockholders Equity | 131.98M | 139.13M | 123.02M | 94.76M | 101.51M |
Cash Flow | |||||
| Free Cash Flow | -42.11M | 51.47M | 56.12M | -6.06M | 41.97M |
| Operating Cash Flow | -31.30M | 57.54M | 71.31M | -3.35M | 42.46M |
| Investing Cash Flow | 62.19M | -25.11M | -9.42M | -31.81M | -1.31M |
| Financing Cash Flow | -28.15M | -30.21M | -63.13M | 38.19M | -10.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$464.80M | 1.16 | 21.36% | 3.17% | 6.12% | 78.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | HK$53.46M | 2.72 | -0.77% | ― | 2.94% | -56.79% | |
52 Neutral | HK$46.66M | -6.31 | -4.22% | ― | -72.66% | -127.43% | |
48 Neutral | HK$40.80M | 10.19 | -12.22% | ― | -57.27% | -190.00% | |
46 Neutral | HK$53.46M | -1.06 | ― | ― | 4.13% | -5.11% | |
44 Neutral | HK$63.03M | 18.02 | -4.04% | ― | 12.29% | 51.28% |